Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to increase

Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to increase

Liver cancer genes cluster into two subsets that correlate to survival

Liver cancer genes cluster into two subsets that correlate to survival

Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients

Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients

Surprise finding could lead to hepatitis C vaccine

Surprise finding could lead to hepatitis C vaccine

Significant advance in the understanding of the hepatitis C virus (HCV)

Significant advance in the understanding of the hepatitis C virus (HCV)

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

Understanding the role of c-Jun in repairing damaged nerve cells could help treat spinal injuries and increase our understanding of cancer

Understanding the role of c-Jun in repairing damaged nerve cells could help treat spinal injuries and increase our understanding of cancer

The EU is contributing €9 million to the “Vigilance against Viral Resistance” (VIRGIL) project

The EU is contributing €9 million to the “Vigilance against Viral Resistance” (VIRGIL) project

Smoking a lot more harmful than previously thought

Smoking a lot more harmful than previously thought

Smoking causes diseases in nearly every organ of the body

Smoking causes diseases in nearly every organ of the body

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

Causes of hepatitis and potential therapies that may improve care presented in study

Causes of hepatitis and potential therapies that may improve care presented in study

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Hepatitis B vaccination for inmates

Hepatitis B vaccination for inmates

Link between iron regulation and the immune system

Link between iron regulation and the immune system

Preclinical data on Histamine's ability to prevent liver damage

Preclinical data on Histamine's ability to prevent liver damage

Mayo Clinic debunks myths cancer myths

Mayo Clinic debunks myths cancer myths